HALO
Halozyme Therapeutics, Inc.
Revenue to net incomeLast 12 months
Key figures
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $1.8B | +39.2% |
| Gross profit | $1.5B | +39.1% |
| Operating income | $674M | +26.6% |
| Net income | $485M | +19.7% |
| EPS | $3.97 | +23.0% |
| Free cash flow | $886M | +64.8% |